NuvoAir is a digital health company that focuses on providing better healthcare experiences for patients living with complex conditions like COPD, CHF, and asthma. They believe that people deserve continuous, proactive care, which is why they offer a virtual-first care solution that combines remote monitoring technology, proprietary biomarkers, deep clinical expertise, and a data-driven infrastructure. NuvoAir works with risk-bearing partners to integrate technology and data, enabling personalized care for each member.

They also provide a patient-centric approach to clinical trials. NuvoAir's products and services are trusted by hospitals, universities, pharma companies, and CROs around the world. Their flagship product, Air Next, is a CE certified medical device and meets international standards.

With headquarters in Boston and a European office in Stockholm, NuvoAir is dedicated to improving the lives of patients and supporting innovative research in the respiratory field. Partner with NuvoAir to unlock the potential of digital healthcare and enhance patient outcomes